Regentis Biomaterials RGNT
NYSE RGNT
$1.85 +0.00 (+0.00%)
As of: Sep 30, 2026 · 3:36 PM EDT

Regentis Biomaterials (RGNT) Current Assets (2025 - 2026)

Updated

Regentis Biomaterials (RGNT) recorded Current Assets of $9.29 million in Q2 2026.

Analysis

Regentis Biomaterials (RGNT) Current Assets (2025 - 2026) Analysis & Trends

At the end of FY2025, Regentis Biomaterials reported Current Assets of $7.62 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Assets (Qtr)
1 Thermo Fisher Scientific 251.30 Bn 230.45 Bn 4.88 Bn 23.37 Bn
2 Abbott Laboratories 174.70 Bn 145.78 Bn 7.27 Bn 24.52 Bn
3 Danaher 158.94 Bn 142.76 Bn 3.61 Bn 13.38 Bn
4 Intuitive Surgical 145.87 Bn 125.42 Bn 1.96 Bn 9.54 Bn
5 Medtronic 111.49 Bn 77.36 Bn 6.34 Bn 24.39 Bn
6 Stryker 106.96 Bn 93.08 Bn 4.50 Bn 14.42 Bn
7 Boston Scientific 63.62 Bn 58.63 Bn 3.85 Bn 7.97 Bn
8 Edwards Lifesciences 50.80 Bn 34.92 Bn 1.35 Bn 6.82 Bn
9 Becton Dickinson 49.59 Bn 46.74 Bn 2.32 Bn 8.14 Bn
10 Regentis Biomaterials 1.08 Mn -7.87 Mn - 9.29 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 9.29 Mn
Dec 31, 2025 7.62 Mn
API Access

Regentis Biomaterials Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=RGNT&period=max&api_key=YOUR_API_KEY